Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Noble

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Thrombosis and Haemostasis|August 22, 2015
Fractal dimension (df) as a new structural biomarker of clot microstructure in different stages of lung cancerNia Anne Davies, Nicholas Kim Harrison, Roger H Keith Morris, et al.
BMC Medical Research Methodology|May 14, 2020
Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guideMatthew Ventresca, Holger J Schünemann, Fergus Macbeth, et al.
Plos Medicine|August 25, 2025
Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesisJustin Jagosh, Mark Pearson, Sarah Greenley, et al.
Blood Advances|February 11, 2021
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancerGary H Lyman, Marc Carrier, Cihan Ay, et al.
Research and Practice in Thrombosis and Haemostasis|April 22, 2026
Clinician perspectives on antithrombotic therapy management in advanced cancer: a multinational qualitative studyElin Baddeley, Carme Font, Isabelle Mahé, et al.
Thrombosis Research|July 12, 2025
"Who am I to say that I'm not going to take it": patient perspectives on decisions about antithrombotic therapy in the context of advanced cancerElin Baddeley, Carme Font, Isabelle Mahé, et al.
Journal of Thrombosis and Haemostasis : JTH|October 11, 2024
Use of antithrombotic therapy and the risk of cardiovascular outcomes and bleeding in cancer patients at the end of life: a Danish nationwide cohort studyMette Søgaard, Marie Ørskov, Martin Jensen, et al.
The Lancet. Healthy Longevity|April 27, 2026
The crucial role of normative ageing in respiratory pathogenesis, Caroline M Weight, Amanda L Tatler, et al.
British Journal of Haematology|September 1, 2025
Anti-thrombotic therapy in patients with cancer at the end of life and associated clinical outcomes: A cohort study using population-linked routinely collected dataSarah J Aldridge, Ashley Akbari, Adrian Edwards, et al.
The Lancet. Haematology|May 30, 2025
Optimising communication to patients with venous thromboembolism: development of a provider toolkitFrederikus A Klok, Scott C Woller, Aviva Schwartz, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Thrombosis and Haemostasis|August 22, 2015
Fractal dimension (df) as a new structural biomarker of clot microstructure in different stages of lung cancerNia Anne Davies, Nicholas Kim Harrison, Roger H Keith Morris, et al.
BMC Medical Research Methodology|May 14, 2020
Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guideMatthew Ventresca, Holger J Schünemann, Fergus Macbeth, et al.
Plos Medicine|August 25, 2025
Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesisJustin Jagosh, Mark Pearson, Sarah Greenley, et al.
Blood Advances|February 11, 2021
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancerGary H Lyman, Marc Carrier, Cihan Ay, et al.
Research and Practice in Thrombosis and Haemostasis|April 22, 2026
Clinician perspectives on antithrombotic therapy management in advanced cancer: a multinational qualitative studyElin Baddeley, Carme Font, Isabelle Mahé, et al.
Thrombosis Research|July 12, 2025
"Who am I to say that I'm not going to take it": patient perspectives on decisions about antithrombotic therapy in the context of advanced cancerElin Baddeley, Carme Font, Isabelle Mahé, et al.
Journal of Thrombosis and Haemostasis : JTH|October 11, 2024
Use of antithrombotic therapy and the risk of cardiovascular outcomes and bleeding in cancer patients at the end of life: a Danish nationwide cohort studyMette Søgaard, Marie Ørskov, Martin Jensen, et al.
The Lancet. Healthy Longevity|April 27, 2026
The crucial role of normative ageing in respiratory pathogenesis, Caroline M Weight, Amanda L Tatler, et al.
British Journal of Haematology|September 1, 2025
Anti-thrombotic therapy in patients with cancer at the end of life and associated clinical outcomes: A cohort study using population-linked routinely collected dataSarah J Aldridge, Ashley Akbari, Adrian Edwards, et al.
The Lancet. Haematology|May 30, 2025
Optimising communication to patients with venous thromboembolism: development of a provider toolkitFrederikus A Klok, Scott C Woller, Aviva Schwartz, et al.
Pageof 14